|
Gastric Cancer
According to the US National Cancer Institute (NCI), approximately
760,000 cases of stomach cancer are diagnosed worldwide and it is the
second leading cause of cancer-related deaths. Thanks to its excellent
multidisciplinary treatments, NUH has managed to improve the survival
rates of its gastric cancer patients. The proportion of patients with
high-risk stomach cancer (Stage II-IV) who are alive at 2 years after
surgery and chemo-radiotherapy in NUH is 69.4%. This fares well against
the 60.0% reported by the US Intergroup 0116 Study and 40.5% in an
Australian multicentre study report. |
